Pharmaceutical company
News Pharma
Pakistan
Represent this company?Verified companies can submit portfolio corrections, documents and approved company information.Claim / verify profile →
8products
5generics
1therapeutic areas
8current prices
Portfolio intelligence
Therapeutic mix
Unclassified 6Third-generation cephalosporins 2
Company portfolio
8 resultsProducts
| Brand | Generic | Strength | Form | Pack | Registration | Current price |
|---|---|---|---|---|---|---|
| New-Xime | Cefixime | 100 mg/5 mL | Suspension | 30ml | 106280 | PKR 262.59 |
| New-Xime | Cefixime | 400 mg | Capsule | 5’s | 107149 | PKR 470.54 |
| New-Zidime | Ceftazidime | 1 g | IV/IM injection | 1's | 094542 | PKR 381.15 |
| New-Zidime | Ceftazidime | 500 mg | IV/IM injection | 1's | 094543 | PKR 202.92 |
| New-Zone | Ceftriaxone | 1 g | IM injection | 1's | 104616 | PKR 495.32 |
| New-Zone | Ceftriaxone | 1 g | IV injection | 1's | 083168 | PKR 495.32 |
| News-Ibu | Ibuprofen | 100 mg/5 mL | Suspension | 120 ml | 114180 | PKR 80.56 |
| News-Zol | Metronidazole | 200 mg/5 mL | Suspension | 120ml | 113867 | PKR 84.17 |